Tolerance to efficacy of itraconazole in treatment of systemic mycoses: Preliminary results

Twelve patients with mycotic infections were treated with itraconazole during a one-year period. Patients had the following conditions: coccidioidomycosis (three), histoplasmosis (three), mucocutaneous candidosis (two), aspergillosis (three), and urinary tract infection due to Torulopsis glabrata (o...

Full description

Saved in:
Bibliographic Details
Published in:Reviews of infectious diseases 1987-01, Vol.9, p.no. su 1-no. su 1
Main Authors: Phillips, P, Fetchick, R, Weisman, I, Foshee, S, Graybill, R
Format: Article
Language:English
Subjects:
Aspergillus
Torulopsis glabrata
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Twelve patients with mycotic infections were treated with itraconazole during a one-year period. Patients had the following conditions: coccidioidomycosis (three), histoplasmosis (three), mucocutaneous candidosis (two), aspergillosis (three), and urinary tract infection due to Torulopsis glabrata (one). The daily dose of itraconazole ranged from 100 to 200 mg. Ten of the 12 cases were assessable. Clinical improvement was observed in six patients, two with coccidioidomycosis, two with mucocutaneous candidosis, one with histoplasmosis, and one with aspergilloma. Four patients did not respond to therapy; two of these patients had aspergillosis, one had histoplasmosis, and one had T. glabrata infection. No adverse effect were attributable to itraconazole.
ISSN:0162-0886